Company strengthens AI and technology leadership as it advances next-generation precision oncology platform CHICAGO, IL – January 27, 2026 – SimBioSys®, an AI-driven precision medicine company revolutionizing how cancer is understood and treated, today announced the appointment of Senthil Periaswamy,…
SOLUTIONS
- TumorSight Viz
- TumorSight RISK
- PhenoScope